Re: Laparoscopic Sleeve Gastrectomy Effects on Overactive Bladder Symptoms

Obesity increases the risk of several comorbidities. Though the relationship between a variety of urogenital complications and morbid obesity (MO) has been demonstrated, the information showing a relationship between overactive bladder (OAB) and MO is limited. Laparoscopic sleeve gastrectomy (LSG)...

Full description

Bibliographic Details
Main Author: Lokman İrkılata
Format: Article
Language:English
Published: Galenos Yayinevi 2015-09-01
Series:Journal of Urological Surgery
Online Access:http://jurolsurgery.org/article_9801/Re-Laparoscopic-Sleeve-Gastrectomy-Effects-On-Overactive-Bladder-Symptoms
id doaj-baceed0dfcdb4d32bc6d0164d2b232d5
record_format Article
spelling doaj-baceed0dfcdb4d32bc6d0164d2b232d52020-11-24T22:12:49ZengGalenos YayineviJournal of Urological Surgery2148-95802015-09-012315815810.4274/jus.2015.03.001Re: Laparoscopic Sleeve Gastrectomy Effects on Overactive Bladder SymptomsLokman İrkılata Obesity increases the risk of several comorbidities. Though the relationship between a variety of urogenital complications and morbid obesity (MO) has been demonstrated, the information showing a relationship between overactive bladder (OAB) and MO is limited. Laparoscopic sleeve gastrectomy (LSG) is currently the most commonly chosen surgical procedure for obesity. Recently, Palleschi et al. assessed the prevalence of OAB in the MO population and the resolution of these symptoms after LSG. They included 120 patients (60 female-male) undergoing LSG in their study group. They created a control group of 120 patients (60 female-male) with the same criteria who were waiting for LSG. The patient group recorded a 3-day voiding diary (VD) and completed OAB short-form questionnaire (OABq-SF) 1 week before and 180 days after surgery. OAB diagnosis was present in 35% of the patient group and 28% of the control group. In the MO patient and control groups, OAB was found at higher rates in females than in males. In the patient group, a significant improvement was found by comparing OABq-SF scores and VD parameters before and after LSG. There was no change found in the OABq-SF scores and VD parameters in the control group. Treatment of obesity with LSG provided an improvement in OAB symptoms. When the increasing rate of bariatric surgery in our country in recent times is considered, this is a very good study showing both the relationship between MO and OAB, and the improvement in OAB symptoms with obesity treatment.http://jurolsurgery.org/article_9801/Re-Laparoscopic-Sleeve-Gastrectomy-Effects-On-Overactive-Bladder-Symptoms
collection DOAJ
language English
format Article
sources DOAJ
author Lokman İrkılata
spellingShingle Lokman İrkılata
Re: Laparoscopic Sleeve Gastrectomy Effects on Overactive Bladder Symptoms
Journal of Urological Surgery
author_facet Lokman İrkılata
author_sort Lokman İrkılata
title Re: Laparoscopic Sleeve Gastrectomy Effects on Overactive Bladder Symptoms
title_short Re: Laparoscopic Sleeve Gastrectomy Effects on Overactive Bladder Symptoms
title_full Re: Laparoscopic Sleeve Gastrectomy Effects on Overactive Bladder Symptoms
title_fullStr Re: Laparoscopic Sleeve Gastrectomy Effects on Overactive Bladder Symptoms
title_full_unstemmed Re: Laparoscopic Sleeve Gastrectomy Effects on Overactive Bladder Symptoms
title_sort re: laparoscopic sleeve gastrectomy effects on overactive bladder symptoms
publisher Galenos Yayinevi
series Journal of Urological Surgery
issn 2148-9580
publishDate 2015-09-01
description Obesity increases the risk of several comorbidities. Though the relationship between a variety of urogenital complications and morbid obesity (MO) has been demonstrated, the information showing a relationship between overactive bladder (OAB) and MO is limited. Laparoscopic sleeve gastrectomy (LSG) is currently the most commonly chosen surgical procedure for obesity. Recently, Palleschi et al. assessed the prevalence of OAB in the MO population and the resolution of these symptoms after LSG. They included 120 patients (60 female-male) undergoing LSG in their study group. They created a control group of 120 patients (60 female-male) with the same criteria who were waiting for LSG. The patient group recorded a 3-day voiding diary (VD) and completed OAB short-form questionnaire (OABq-SF) 1 week before and 180 days after surgery. OAB diagnosis was present in 35% of the patient group and 28% of the control group. In the MO patient and control groups, OAB was found at higher rates in females than in males. In the patient group, a significant improvement was found by comparing OABq-SF scores and VD parameters before and after LSG. There was no change found in the OABq-SF scores and VD parameters in the control group. Treatment of obesity with LSG provided an improvement in OAB symptoms. When the increasing rate of bariatric surgery in our country in recent times is considered, this is a very good study showing both the relationship between MO and OAB, and the improvement in OAB symptoms with obesity treatment.
url http://jurolsurgery.org/article_9801/Re-Laparoscopic-Sleeve-Gastrectomy-Effects-On-Overactive-Bladder-Symptoms
work_keys_str_mv AT lokmanirkılata relaparoscopicsleevegastrectomyeffectsonoveractivebladdersymptoms
_version_ 1725802249058254848